Effectiveness of digital adherence technologies in improving tuberculosis treatment outcomes in four countries: a pragmatic cluster randomised trial protocol

被引:7
作者
Jerene, Degu [1 ]
Levy, Jens [1 ]
van Kalmthout, Kristian [1 ]
Rest, Job van [1 ]
McQuaid, Christopher Finn [2 ]
Quaife, Matthew [2 ]
Charalambous, Salome [3 ]
Gamazina, Katya [4 ]
Garfin, A. M. Celina [5 ]
Mleoh, Liberate [6 ]
Terleieva, Yana [7 ]
Bogdanov, Alexsey [4 ]
Maraba, Noriah [3 ]
Fielding, Katherine [2 ]
机构
[1] KNCV TB Fdn, Div TB Eliminat & Hlth Syst Strengthening, The Hague, Netherlands
[2] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, TB Ctr, Dept Infect Dis Epidemiol, London, England
[3] Aurum Inst, Johannesburg, South Africa
[4] Program Appropriate Technol Hlth, Kiev, Ukraine
[5] Dis Prevent & Control Bur, Dept Hlth, Infect Dis Prevent & Control Div, Manila, Philippines
[6] Dept Prevent Serv, Natl TB & Leprosy Programme, Dodoma, Tanzania
[7] Dept Coordinat TB Treatment Programs, Kiev, Ukraine
来源
BMJ OPEN | 2023年 / 13卷 / 03期
关键词
Tuberculosis; Public health; Tropical medicine; Epidemiology;
D O I
10.1136/bmjopen-2022-068685
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Successful treatment of tuberculosis depends to a large extent on good adherence to treatment regimens, which relies on directly observed treatment (DOT). This in turn requires frequent visits to health facilities. High costs to patients, stigma and burden to the health system challenged the DOT approach. Digital adherence technologies (DATs) have emerged as possibly more feasible alternatives to DOT but there is conflicting evidence on their effectiveness and feasibility. Our primary objective is to evaluate whether the implementation of DATs with daily monitoring and a differentiated response to patient adherence would reduce poor treatment outcomes compared with the standard of care (SOC). Our secondary objectives include: to evaluate the proportion of patients lost to follow-up; to compare effectiveness by DAT type; to evaluate the feasibility and acceptability of DATs; to describe factors affecting the longitudinal engagement of patients with the intervention and to use a simple model to estimate the epidemiological impact and cost-effectiveness of the intervention from a health system perspective.Methods and analysis This is a pragmatic two-arm cluster-randomised trial in the Philippines, South Africa, Tanzania and Ukraine, with health facilities as the unit of randomisation. Facilities will first be randomised to either the DAT or SOC arm, and then the DAT arm will be further randomised into medication sleeve/labels or smart pill box in a 1:1:2 ratio for the smart pill box, medication sleeve/label or the SOC respectively. We will use data from the digital adherence platform and routine health facility records for analysis. In the main analysis, we will employ an intention-to-treat approach to evaluate treatment outcomes.Ethics and dissemination The study has been approved by the WHO Research Ethics Review Committee (0003296), and by country-specific committees. The results will be shared at national and international meetings and will be published in peer-reviewed journals.
引用
收藏
页数:9
相关论文
共 22 条
  • [11] Directly observed therapy for treating tuberculosis
    Karumbi, Jamlick
    Garner, Paul
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (05):
  • [12] Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis
    Liu, Xiaoqiu
    Blaschke, Terrence
    Thomas, Bruce
    De Geest, Sabina
    Jiang, Shiwen
    Gao, Yongxin
    Li, Xinxu
    Buono, Elizabeth
    Buchanan, Stacy
    Zhang, Zhiying
    Huan, Shitong
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2017, 14 (10)
  • [13] Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial
    Liu, Xiaoqiu
    Lewis, James J.
    Zhang, Hui
    Lu, Wei
    Zhang, Shun
    Zheng, Guilan
    Bai, Liqiong
    Li, Jun
    Li, Xue
    Chen, Hongguang
    Liu, Mingming
    Chen, Rong
    Chi, Junying
    Lu, Jian
    Huan, Shitong
    Cheng, Shiming
    Wang, Lixia
    Jiang, Shiwen
    Chin, Daniel P.
    Fielding, Katherine L.
    [J]. PLOS MEDICINE, 2015, 12 (09)
  • [14] Impact of a Daily SMS Medication Reminder System on Tuberculosis Treatment Outcomes: A Randomized Controlled Trial
    Mohammed, Shama
    Glennerster, Rachel
    Khan, Aamir J.
    [J]. PLOS ONE, 2016, 11 (11):
  • [15] Moulton LH, 2017, Cluster randomised trials, V2nd
  • [16] Raviglione Raviglione M. M., 2013, Global strategy and targets for tuberculosis prevention, care and control after 2015
  • [17] Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials
    Ridho, Abdurahman
    Alfian, Sofa D.
    van Boven, Job F. M.
    Levita, Jutti
    Yalcin, Esin Aki
    Le, Ly
    Alffenaar, Jan-Willem
    Hak, Eelko
    Abdulah, Rizky
    Pradipta, Ivan S.
    [J]. JOURNAL OF MEDICAL INTERNET RESEARCH, 2022, 24 (02)
  • [18] Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities
    Subbaraman, Ramnath
    de Mondesert, Laura
    Musiimenta, Angella
    Pai, Madhukar
    Mayer, Kenneth H.
    Thomas, Beena E.
    Haberer, Jessica
    [J]. BMJ GLOBAL HEALTH, 2018, 3 (05):
  • [19] Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial
    Tadesse, Amare W.
    Mohammed, Zemedu
    Foster, Nicola
    Quaife, Matthew
    McQuaid, Christopher Finn
    Levy, Jens
    van Kalmthout, Kristian
    van Rest, Job
    Jerene, Degu
    Abdurhman, Tofik
    Yazew, Hiwot
    Umeta, Demekech G.
    Assefa, Demelash
    Weldemichael, Gedion T.
    Bedru, Ahmed
    Letta, Taye
    Fielding, Katherine L.
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [20] Explaining Differences in the Acceptability of 99DOTS, a Cell Phone-Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers
    Thomas, Beena E.
    Kumar, J. Vignesh
    Onongaya, Chidiebere
    Bhatt, Spurthi N.
    Galivanche, Amith
    Periyasamy, Murugesan
    Chiranjeevi, M.
    Khandewale, Amit Subhash
    Ramachandran, Geetha
    Shah, Daksha
    Haberer, Jessica E.
    Mayer, Kenneth H.
    Subbaraman, Ramnath
    [J]. JMIR MHEALTH AND UHEALTH, 2020, 8 (07):